Skip to main content
. 2018 Apr 10;20:65. doi: 10.1186/s13075-018-1567-2

Fig. 1.

Fig. 1

Flow scheme of patient enrollment, grouping according to treatment and assessment of treatment outcomes. IgG4-RD, IgG4-related disease; GC, glucocorticoid; IM, immunosuppressive agents